Dr. Jason Luke, Director of Cancer Immunotherapeutic Center at UPMC Hillman Cancer Center and Kyleigh LiPira, CEO of the Melanoma Research F
3 de jun. de 2022 ·
9m 15s
Regístrate gratis
Escucha este episodio y muchos más. ¡Disfruta de los mejores podcasts en Spreaker!
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
Skin cancer remains the most common cancer in the U.S. despite preventative sun care measures like sunscreen use and UV-protective clothing. Fortunately, scientific advances have helped bring hope to patients...
mostra más
Skin cancer remains the most common cancer in the U.S. despite preventative sun care measures like sunscreen use and UV-protective clothing. Fortunately, scientific advances have helped bring hope to patients facing advanced melanoma. Dr. Jason Luke, Director of Cancer Immunotherapeutic Center at UPMC Hillman Cancer Center, and Kyleigh LiPira, Melanoma Research Foundation, First-of-its-Kind Dual immunotherapy treatment for advanced melanoma patients talk about a new treatment option and what it may mean for patients facing the disease.
mostra menos
Información
| Autor | BizTalkPodcasts |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
